These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9591301)

  • 61. The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study.
    Anlar B; Yalaz K; Imir T; Turanli G
    Eur Neurol; 1994; 34(1):44-7. PubMed ID: 7511102
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comparison of the results of the treatment of patients with SSPE using various immunomodulating preparations].
    Sobczyk W; Kulczycki J; Piłkowska E; Iwińska B; Milewska D; Szmigielski S
    Neurol Neurochir Pol; 1991; 25(5):626-33. PubMed ID: 1725554
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Place of magistral preparations to continue the treatment if the drug is commercially stopped worldwide? A case report of a 10-year-old child with subacute sclerosing panencephalitis (SSPE) requiring inosiplex.
    Le Cras R; Mazet R; Dubois-Teklali F; Sabourdy C; Chanoine S; Lehmann A; Morin A; Leenhardt J; Durand M; Desruet MD; Bedouch P
    Emerg Microbes Infect; 2023 Dec; 12(1):2148563. PubMed ID: 36458570
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lymphocyte subsets, TNF alpha and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients.
    Anlar B; Guven A; Köse G; Okur H; Kose O; Aydin OF; Kabakus N; Altunbasak S; Herguner O; Sonmez M; Serdaroglu A
    J Neuroimmunol; 2005 Jun; 163(1-2):195-8. PubMed ID: 15885323
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical effects of MND-19 (Inosiplex) on subacute sclerosing panencephalitis--a multi-institutional collaborative study--The Inosiplex-SSPE Research Committee.
    Fukuyama Y; Nihei K; Matsumoto S; Ebina T; Kamoshita S; Sato T; Arima M; Yabuuchi H; Ueda S; Ohtahara S
    Brain Dev; 1987; 9(3):270-82. PubMed ID: 2444125
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SSPE incidence, therapy receive renewed attention.
    Gunby P
    JAMA; 1981 Aug; 246(9):927, 931-2. PubMed ID: 6166765
    [No Abstract]   [Full Text] [Related]  

  • 67. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis.
    Hosoya M; Shigeta S; Mori S; Tomoda A; Shiraishi S; Miike T; Suzuki H
    Antimicrob Agents Chemother; 2001 Mar; 45(3):943-5. PubMed ID: 11181386
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Subacute sclerosing panencephalitis.
    Gascon GG; Crowell J; Stigsby B; Yamani S
    Neurology; 1993 Feb; 43(2):454-5. PubMed ID: 7679784
    [No Abstract]   [Full Text] [Related]  

  • 69. Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma.
    Buckner JC; Malkin MG; Reed E; Cascino TL; Reid JM; Ames MM; Tong WP; Lim S; Figg WD
    Mayo Clin Proc; 1999 Feb; 74(2):137-45. PubMed ID: 10069350
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Current developments in the management of subacute sclerosing panencephalitis.
    Panagariya A; Sureka RK; Aurora A
    J Assoc Physicians India; 1998 Feb; 46(2):218-20. PubMed ID: 11273118
    [No Abstract]   [Full Text] [Related]  

  • 71. Phase II study of antineoplaston A10 and AS2-1 in patients with recurrent diffuse intrinsic brain stem glioma: a preliminary report.
    Burzynski SR; Lewy RI; Weaver RA; Axler ML; Janicki TJ; Jurida GF; Paszkowiak JK; Szymkowski BG; Khan MI; Bestak M
    Drugs R D; 2003; 4(2):91-101. PubMed ID: 12718563
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Progressive CT abnormalities despite clinical improvement in SSPE treated with inosiplex.
    Noetzel MJ; Dodson WE
    Ann Neurol; 1983 Apr; 13(4):457-60. PubMed ID: 6188412
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adult-onset subacute sclerosing panencephalitis first seen as craniocervical myoclonus.
    Vela L; Garcia-Merino A; Escamilla C
    Mov Disord; 1997 May; 12(3):462-4. PubMed ID: 9159751
    [No Abstract]   [Full Text] [Related]  

  • 74. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon.
    Anlar B; Yalaz K; Oktem F; Köse G
    Neurology; 1997 Feb; 48(2):526-8. PubMed ID: 9040751
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Improvement of SSPE by intrathecal infusion of alpha-IFN.
    Kurata T; Matsubara E; Yokoyama M; Nagano I; Shoji M; Abe K
    Neurology; 2004 Jul; 63(2):398-9. PubMed ID: 15277654
    [No Abstract]   [Full Text] [Related]  

  • 76. Early onset and rapidly progressive subacute sclerosing panencephalitis after congenital measles infection.
    Cruzado D; Masserey-Spicher V; Roux L; Delavelle J; Picard F; Haenggeli CA
    Eur J Pediatr; 2002 Aug; 161(8):438-41. PubMed ID: 12172828
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Primary Psychiatric Manifestations of Subacute Sclerosing Panencephalitis: A Case Report and Literature Review.
    Reddy B; Das S; Guruprasad S
    Psychosomatics; 2018; 59(4):408-412. PubMed ID: 29402453
    [No Abstract]   [Full Text] [Related]  

  • 78. Retrospective evaluation of interferon-beta treatment in subacute sclerosing panencephalitis.
    Anlar B; Aydin OF; Guven A; Sonmez FM; Kose G; Herguner O
    Clin Ther; 2004 Nov; 26(11):1890-4. PubMed ID: 15639700
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inosiplex for SSPE.
    Jones C
    Lancet; 1982 Aug; 2(8296):495. PubMed ID: 6180266
    [No Abstract]   [Full Text] [Related]  

  • 80. Inosiplex for SSPE.
    Chalmers TC; Smith H
    Lancet; 1982 Jun; 1(8287):1475. PubMed ID: 6177984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.